Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;23(2):115-128.
doi: 10.1038/s41583-021-00542-9. Epub 2021 Dec 14.

Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

Affiliations
Review

Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

Javier Blesa et al. Nat Rev Neurosci. 2022 Feb.

Abstract

For the last two decades, pathogenic concepts in Parkinson disease (PD) have revolved around the toxicity and spread of α-synuclein. Thus, α-synuclein would follow caudo-rostral propagation from the periphery to the central nervous system, first producing non-motor manifestations (such as constipation, sleep disorders and hyposmia), and subsequently impinging upon the mesencephalon to account for the cardinal motor features before reaching the neocortex as the disease evolves towards dementia. This model is the prevailing theory of the principal neurobiological mechanism of disease. Here, we scrutinize the temporal evolution of motor and non-motor manifestations in PD and suggest that, even though the postulated bottom-up mechanisms are likely to be involved, early involvement of the nigrostriatal system is a key and prominent pathophysiological mechanism. Upcoming studies of detailed clinical manifestations with newer neuroimaging techniques will allow us to more closely define, in vivo, the role of α-synuclein aggregates with respect to neuronal loss during the onset and progression of PD.

PubMed Disclaimer

References

    1. de Lau, L. M. & Breteler, M. M. Epidemiology of Parkinson’s disease. Lancet Neurol. 5, 525–535 (2006). - PubMed - DOI
    1. Tysnes, O.-B. & Storstein, A. Epidemiology of Parkinson’s disease. J. Neural Transm. 124, 901–905 (2017). - PubMed - DOI
    1. Bach, J.-P., Ziegler, U., Deuschl, G., Dodel, R. & Doblhammer-Reiter, G. Projected numbers of people with movement disorders in the years 2030 and 2050. Mov. Disord. 26, 2286–2290 (2011). - PubMed - DOI
    1. Dorsey, E. R. et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68, 384–386 (2007). - PubMed - DOI
    1. Bloem, B. R., Okun, M. S. & Klein, C. Parkinson’s disease. Lancet 397, 2284–2303 (2021). - PubMed - DOI

Publication types

LinkOut - more resources